How much is the nanopharmaceuticals market worth, and how is it expected to expand?
The nanopharmaceuticals market size has grown rapidly in recent years. It will grow from $95.21 $ billion in 2024 to $112.49 $ billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to the demand for effective treatment, growing awareness of nanopharmaceuticals, demand for targeted therapies, increasing incidences of neurodegenerative diseases, and the aging population.
The nanopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $216.39 $ billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to the growing prevalence of chronic diseases, growing research and development, growing investments in healthcare, growing demand for personalized medicine, and increasing prevalence of cancers. Major trends in the forecast period include the integration of nanotechnology with other emerging technologies, advancements in nano-enabled drug delivery, advances in biotechnology and genomics, integration of AI, machine learning and computational modeling, and technological advancement.
Get Your Free Sample of The Global Nanopharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19608&type=smp
Which industry factors have accelerated the nanopharmaceuticals market’s expansion?
The rising prevalence of chronic diseases is expected to propel the growth of the nanopharmaceuticals market going forward. Chronic diseases are long-lasting conditions that typically require ongoing medical attention and management over years or even a lifetime, such as cancer, diabetes, heart disease, asthma, and others. The prevalence of chronic diseases is fueled by factors such as unhealthy diets, lack of physical activity, tobacco use, excessive alcohol consumption, genetic predisposition, and environmental influences. Nanopharmaceuticals are used for chronic diseases by providing targeted drug delivery, enhanced bioavailability, controlled release, reduced side effects, and advanced combination therapies, improving treatment efficacy and patient outcomes. For instance, in April 2022, according to the National Association of Chronic Disease Directors (NACDD), a US-based non-profit organization, almost 60 % of adult Americans have at least one chronic disease, and approximately 40% of American adults have multiple chronic conditions (MCC), and this is expected to cost the US economy 2 trillion dollars annually, or $8,600 per person by 2030. Therefore, the rising prevalence of chronic diseases is driving the growth of the nanopharmaceuticals market.
What are the primary segments of the nanopharmaceuticals market?
The nanopharmaceuticalsmarket covered in this report is segmented –
1) By Type: Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion, Nanoemulsion, Other Product Types
2) By Route Of Administration: Oral, Injectable, Topical, Pulmonary, Other Routes Of Administration
3) By Application: Oncology, Neurology, Anti-inflammatory, Anti-infective, Cardiovascular, Other Applications
4) By End-User: Hospitals And Clinics, Specialty Pharmacies, Research Institutions, Other End Users
Subsegments:
1) By Liposomes: Conventional Liposomes, Pegylated Liposomes, Cationic Liposomes, Anionic Liposomes, Immunoliposomes, Stealth Liposomes, Thermosensitive Liposomes,
2) By Polymeric Micelles: Block Copolymer Micelles, Amphiphilic Polymer Micelles, Biodegradable Polymeric Micelles, Nanoparticle-Polymer Hybrid Micelles, pH-Sensitive Micelles, Thermo-responsive Micelles
3) By Solid Lipid Nanoparticles (SLNs): Conventional SLNs, Nanostructured Lipid Carriers (NLCs), SLNs for Drug Delivery, SLNs for Cosmetic Applications, SLNs with Targeting Ligands, SLNs for Vaccine Delivery
4) By Microemulsion: Oil-in-Water (O/W) Microemulsions, Water-in-Oil (W/O) Microemulsions, Multi-Phase Microemulsions, Microemulsions for Drug Delivery, Microemulsions in Cosmetic Applications, Microemulsions with Active Ingredients
5) By Nanoemulsion: Oil-in-Water (O/W) Nanoemulsions, Water-in-Oil (W/O) Nanoemulsions, Nanoemulsions for Parenteral Administration, Nanoemulsions for Oral Delivery, Nanoemulsions with Enhanced Stability, Nanoemulsions in Food Applications
6) By Other Product Types: Nanocrystals, Dendrimers, Nanocomposites, Nanospheres, Nanotubes, Quantum Dots, Magnetic Nanoparticles
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/nanopharmaceuticals-global-market-report
Which firms are leading the nanopharmaceuticals market?
Major companies operating in the nanopharmaceuticals market are Selecta Biosciences Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Stryker Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Novovax Inc., OSI Pharmaceuticals Inc., Par Pharmaceutial Inc., Samyang Biopharm Corporation
Which market trends are set to define the future of the nanopharmaceuticals market?
Major companies operating in the nanopharmaceuticals market are adopting a strategic partnerships approach to provide essential communication services to individuals, businesses, and governments. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in April 2024, Nanoform Finland Plc, a Finland-based nanoparticle medicine company, partnered with CBC Co. Ltd. a Japan-based development-type trading company to explore opportunities for Nanoform’s advanced nanomedicine engineering technologies. This strategic collaboration marks a key milestone in their efforts to leverage cutting-edge nanotechnology to enhance medicines for patients worldwide.
Which geographic trends are shaping the nanopharmaceuticals market, and which region has the highest market share?
North America was the largest region in the global nanopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Nanopharmaceuticals Market Report 2025 Offer?
The nanopharmaceuticals market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Nanopharmaceuticals are a class of pharmaceutical drugs that utilize nanotechnology for therapeutic agents’ delivery, targeting, and efficacy. These drugs are formulated at the nanoscale (typically 1 to 100 nanometers) and designed to improve drug solubility, stability, bioavailability, and targeted delivery to specific cells or tissues. Nanopharmaceuticals represent a cutting-edge approach in medicine, offering the potential for more precise, effective, and safer treatments for a wide range of diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19608
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
